Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Tumor Growth”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Ended earlyNCT00982696
What this trial is testing

Treatment of Advanced Head and Neck Cancer

Who this might be right for
Carcinoma, Squamous Cell of Head and Neck
Milton S. Hershey Medical Center 5
Testing effectiveness (Phase 2)Study completedNCT00891579
What this trial is testing

Study of Pemetrexed Versus Gefitinib in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy Without Epidermal Growth Factor Receptor (EGFR) Mutations

Who this might be right for
Non Small Cell Lung Cancer
Chinese Society of Lung Cancer 161
Not applicableLooking for participantsNCT06542796
What this trial is testing

Study on the Classification of Comprehensive Treatment Effect of Hepatocellular Carcinoma

Who this might be right for
Hepatocellular CarcinomaImmunotherapy
Second Affiliated Hospital, Zhejiang University, School of Medicine 100
Testing effectiveness (Phase 2)Study completedNCT00314262
What this trial is testing

Phase I/II Study of Chemoprevention With EGFR and COX-2 Inhibitor

Who this might be right for
Precancerous Conditions
Emory University 17
Testing effectiveness (Phase 2)Active Not RecruitingNCT05694936
What this trial is testing

Combining Sodium Valproate With Standard-of-care EGFR (Epidermal Growth Factor Receptor) Monoclonal Antibody Treatment in Patients With Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Australasian Gastro-Intestinal Trials Group 38
Not applicableStudy completedNCT02418234
What this trial is testing

T790M Mutation on ctDNA in Patients With NSCLC After EGFR-TKI Failure

Who this might be right for
Non-small Cell Lung Cancer Stage IIINon-Small-Cell Lung Cancer Metastatic
First People's Hospital of Hangzhou 314
Not applicableStudy completedNCT06606301
What this trial is testing

Immunohistochemical Expression of EGFR in the Patients Having Oral Squamous Cell Carcinoma

Who this might be right for
Oral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity Cancer
Combined Military Hospital, Pakistan 61
Not applicableApproved For MarketingNCT04535557
What this trial is testing

An Expanded Access Protocol for Mobocertinib in Refractory Non-small Cell Lung Cancer (NSCLC) Participants With Epidermal Growth Factor Receptor (EGFR) Exon20 Insertion Mutations

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Millennium Pharmaceuticals, Inc.
Large-scale testing (Phase 3)Looking for participantsNCT07413939
What this trial is testing

RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive

Who this might be right for
HER2-positive Breast Cancer
Hoffmann-La Roche 650
Very early researchStudy completedNCT02806817
What this trial is testing

ME-344 in Early HER2-negative Breast Cancer With Antiangiogenic-induced Mitochondrial Metabolism

Who this might be right for
Breast CancerHuman Epidermal Growth Factor 2 Negative Carcinoma of BreastEarly-Stage Breast Carcinoma
Centro Nacional de Investigaciones Oncologicas CARLOS III 40
Not applicableStudy completedNCT01887314
What this trial is testing

Efficacy Study of Ginger (Zingiber Officinale) Extract "Ginpax" to Manage Nausea in Cancer Patients Receiving High Emetogenic Treatments and Standard Anti-emetogenic Therapy

Who this might be right for
CancerNauseaVomiting
Helsinn Healthcare SA 250
Testing effectiveness (Phase 2)Looking for participantsNCT06452706
What this trial is testing

The Clinical Trial of TQB2102 for Injection Against Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer

Who this might be right for
Breast Cancer
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd. 42
Early research (Phase 1)Study completedNCT00563316
What this trial is testing

Effect of Panitumumab on the Pharmacokinetics of Irinotecan

Who this might be right for
Metastatic Colorectal Cancer
Amgen 28
Early research (Phase 1)Active Not RecruitingNCT07557004
What this trial is testing

SH3765 Tablets in Combination With Fulvestrant in Patients With HR+/HER2- Advanced Breast Cancer.

Who this might be right for
HR+ / HER2- Advanced Breast Cancer
Nanjing Sanhome Pharmaceutical, Co., Ltd. 30
Testing effectiveness (Phase 2)Study completedNCT01833572
What this trial is testing

Preoperative Gefitinib for EGFR Mutant II-IIIa NSCLC (ECTOP-1001)

Who this might be right for
Non-small-cell Lung Cancer
Fudan University 36
Early research (Phase 1)Study completedNCT02374645
What this trial is testing

A Phase I Study of Safety and Pharmacokinetics of Volitinib in Combination With Gefitinib in EGFR(+) NSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Hutchison Medipharma Limited 64
Early research (Phase 1)Study completedNCT01962532
What this trial is testing

Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Patients With Advanced or Refractory Solid Tumors or Lymphoma

Who this might be right for
NeoplasmsLymphomaAdenocarcinoma+1 more
Janssen Research & Development, LLC 19
Not applicableStudy completedNCT01657695
What this trial is testing

Hepatocellular Carcinoma Growth and Molecular Aggressiveness

Who this might be right for
CirrhosisHepatocellular Carcinoma
Prof. Facchinetti Fabio 78
Not applicableStudy completedNCT02204800
What this trial is testing

Active Surveillance of the Small Renal Mass

Who this might be right for
Small Renal Mass, Kidney Cancer
Yale University 4
Testing effectiveness (Phase 2)Study completedNCT03321981
What this trial is testing

MCLA-128 With Trastuzumab/Chemotherapy in HER2+ and With Endocrine Therapy in ER+ and Low HER2 Breast Cancer.

Who this might be right for
Breast Cancer Metastatic
Merus B.V. 105
Next Page